Digital Health
Also, annalise.ai has made key executive appointments to support its global expansion.
It offers one flat rate for individual or group counselling.
The cuffless device uses a sensor array over the radial artery to produce a pressure waveform that's used to determine systolic and diastolic blood pressure.
It has been approved as a prescription-only software-as-a-medical device in the US.
The company has received backing from the state government of Western Australia.
The funds will support its expansion across India.
Happify Health chief strategy officer Chris Wasden discusses the company's partnership strategy, the business environment for digital therapeutics and how to encourage physician uptake.
However, the review noted some concerns still need to be addressed, like data privacy and security.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.